Profits and Promotion Under Attack

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-09-01-2001, Volume 0, Issue 0

As policy makers struggle to devise a pharmacy benefit for Medicare patients, pressure mounts to impose spending limits on medications. In turn, consumer activists are challenging industry’s longtime claim that price controls will reduce investment in R&D for life-saving therapies.